The Establishment of an In Vivo HIV-1 Infection Model in Humanized B-NSG Mice

Overview

Journal Virol Sin

Specialty Microbiology

Date 2019 Dec 22

PMID 31863357

Citations 1

Authors

Tian-Jiao Fan

Li Sun

Xian-Guang Yang

Xia Jin

Wei-Wei Sun

Jian-Hua Wang

Affiliations

Soon will be listed here.

Abstract

Suitable animal models for human immunodeficiency virus type 1 (HIV-1) infection are important for elucidating viral pathogenesis and evaluating antiviral strategies in vivo. The B-NSG (NOD-PrkdcscidIl2rgtm1/Bcge) mice that have severe immune defect phenotype are examined for the suitability of such a model in this study. Human peripheral blood mononuclear cells (PBMCs) were engrafted into B-NSG mice via mouse tail vein injection, and the repopulated human T-lymphocytes were observed at as early as 3-weeks post-transplantation in mouse peripheral blood and several tissues. The humanized mice could be infected by HIV-1, and the infection recapitulated features of T-lymphocyte dynamic observed in HIV-1 infected humans, meanwhile the administration of combination antiretroviral therapy (cART) suppressed viral replication and restored T lymphocyte abnormalities. The establishment of HIV-1 infected humanized B-NSG mice not only provides a model to study virus and T cell interplays, but also can be a useful tool to evaluate antiviral strategies.

Citing Articles

Vaccine strategies for the /HIV copandemic.

Sharan R, Kaushal D NPJ Vaccines. 2020; 5:95.

PMID: 33083030 PMC: 7555484. DOI: 10.1038/s41541-020-00245-9.

References

Honeycutt J, Wahl A, Archin N, Choudhary S, Margolis D, Garcia J . HIV-1 infection, response to treatment and establishment of viral latency in a novel humanized T cell-only mouse (TOM) model. Retrovirology. 2013; 10:121. PMC: 3826870. DOI: 10.1186/1742-4690-10-121. View

Li C, Wang H, Kuang W, Ren X, Song S, Zhu H . Naf1 Regulates HIV-1 Latency by Suppressing Viral Promoter-Driven Gene Expression in Primary CD4+ T Cells. J Virol. 2016; 91(1). PMC: 5165213. DOI: 10.1128/JVI.01830-16. View

McBride J, Striker R . Imbalance in the game of T cells: What can the CD4/CD8 T-cell ratio tell us about HIV and health?. PLoS Pathog. 2017; 13(11):e1006624. PMC: 5667733. DOI: 10.1371/journal.ppat.1006624. View

Ye C, Wang W, Cheng L, Li G, Wen M, Wang Q . Glycosylphosphatidylinositol-Anchored Anti-HIV scFv Efficiently Protects CD4 T Cells from HIV-1 Infection and Deletion in hu-PBL Mice. J Virol. 2016; 91(3). PMC: 5244347. DOI: 10.1128/JVI.01389-16. View

Ito M, Hiramatsu H, Kobayashi K, Suzue K, Kawahata M, Hioki K . NOD/SCID/gamma(c)(null) mouse: an excellent recipient mouse model for engraftment of human cells. Blood. 2002; 100(9):3175-82. DOI: 10.1182/blood-2001-12-0207. View

Wu X, Liu L, Cheung K, Wang H, Lu X, Cheung A . Brain Invasion by CD4(+) T Cells Infected with a Transmitted/Founder HIV-1BJZS7 During Acute Stage in Humanized Mice. J Neuroimmune Pharmacol. 2016; 11(3):572-83. DOI: 10.1007/s11481-016-9654-0. View

Nixon C, Mavigner M, Silvestri G, Garcia J . In Vivo Models of Human Immunodeficiency Virus Persistence and Cure Strategies. J Infect Dis. 2017; 215(suppl_3):S142-S151. PMC: 5410984. DOI: 10.1093/infdis/jiw637. View

Kim K, Choi B, Kim K, Park K, Lee H, Cho Y . A Simple Mouse Model for the Study of Human Immunodeficiency Virus. AIDS Res Hum Retroviruses. 2015; 32(2):194-202. PMC: 4761813. DOI: 10.1089/AID.2015.0211. View

Evans D, Silvestri G . Nonhuman primate models in AIDS research. Curr Opin HIV AIDS. 2013; 8(4):255-61. PMC: 3987953. DOI: 10.1097/COH.0b013e328361cee8. View

10.

Brooks D, Hamer D, Arlen P, Gao L, Bristol G, Kitchen C . Molecular characterization, reactivation, and depletion of latent HIV. Immunity. 2003; 19(3):413-23. DOI: 10.1016/s1074-7613(03)00236-x. View

11.

Dinoso J, Rabi S, Blankson J, Gama L, Mankowski J, Siliciano R . A simian immunodeficiency virus-infected macaque model to study viral reservoirs that persist during highly active antiretroviral therapy. J Virol. 2009; 83(18):9247-57. PMC: 2738256. DOI: 10.1128/JVI.00840-09. View

12.

Covassin L, Jangalwe S, Jouvet N, Laning J, Burzenski L, Shultz L . Human immune system development and survival of non-obese diabetic (NOD)-scid IL2rγ(null) (NSG) mice engrafted with human thymus and autologous haematopoietic stem cells. Clin Exp Immunol. 2013; 174(3):372-88. PMC: 3826304. DOI: 10.1111/cei.12180. View

13.

Strowig T, Rongvaux A, Rathinam C, Takizawa H, Borsotti C, Philbrick W . Transgenic expression of human signal regulatory protein alpha in Rag2-/-gamma(c)-/- mice improves engraftment of human hematopoietic cells in humanized mice. Proc Natl Acad Sci U S A. 2011; 108(32):13218-23. PMC: 3156175. DOI: 10.1073/pnas.1109769108. View

14.

Hessell A, Haigwood N . Animal models in HIV-1 protection and therapy. Curr Opin HIV AIDS. 2015; 10(3):170-6. PMC: 4526147. DOI: 10.1097/COH.0000000000000152. View

15.

McDermott S, Eppert K, Lechman E, Doedens M, Dick J . Comparison of human cord blood engraftment between immunocompromised mouse strains. Blood. 2010; 116(2):193-200. DOI: 10.1182/blood-2010-02-271841. View

16.

Shultz L, Ishikawa F, Greiner D . Humanized mice in translational biomedical research. Nat Rev Immunol. 2007; 7(2):118-30. DOI: 10.1038/nri2017. View

17.

Kline C, Ndjomou J, Franks T, Kiser R, Coalter V, Smedley J . Persistence of viral reservoirs in multiple tissues after antiretroviral therapy suppression in a macaque RT-SHIV model. PLoS One. 2013; 8(12):e84275. PMC: 3867492. DOI: 10.1371/journal.pone.0084275. View

18.

Sun Z, Denton P, Estes J, Othieno F, Wei B, Wege A . Intrarectal transmission, systemic infection, and CD4+ T cell depletion in humanized mice infected with HIV-1. J Exp Med. 2007; 204(4):705-14. PMC: 2118553. DOI: 10.1084/jem.20062411. View

19.

Zhang L, Su L . HIV-1 immunopathogenesis in humanized mouse models. Cell Mol Immunol. 2012; 9(3):237-44. PMC: 3971052. DOI: 10.1038/cmi.2012.7. View

20.

King M, Pearson T, Shultz L, Leif J, Bottino R, Trucco M . A new Hu-PBL model for the study of human islet alloreactivity based on NOD-scid mice bearing a targeted mutation in the IL-2 receptor gamma chain gene. Clin Immunol. 2007; 126(3):303-14. DOI: 10.1016/j.clim.2007.11.001. View